『Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial』のカバーアート

Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial

Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial

無料で聴く

ポッドキャストの詳細を見る
概要
 Episode description: Dr. Geoff Kerchner, Vice President and Global Head of Neurodegeneration at Roche, Basel, Switzerland, discusses the science behind PrevenTRON, a prevention study evaluating trontinemab in individuals with preclinical Alzheimer disease. Keywords: trontinemab, Alzheimer's, Alzheimer disease, dementia, mild cognitive impairment, MCI, amyloid-targeting therapies, Roche, PrevenTRON, TRONTIER, brain health, cognitive health
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません